Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex F Herrera

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 29, 2018
Investigational Antibody-Drug Conjugates for Treatment of B-lineage MalignanciesAlex F Herrera, Arturo Molina
Therapeutic Advances in Hematology|September 14, 2018
Update on the role of brentuximab vedotin in classical Hodgkin lymphomaSarah Tomassetti, Alex F Herrera
Blood|May 25, 2023
The next frontier: enter PD-1 and exit PET scans?Matthew Mei, Alex F Herrera
Hematology. American Society of Hematology. Education Program|December 9, 2022
Incorporating novel agents into frontline treatment of Hodgkin lymphomaSwetha Kambhampati Thiruvengadam, Alex F Herrera
Hematology/Oncology Clinics of North America|February 10, 2026
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin LymphomaAlex F Herrera, Alison J Moskowitz
Blood Advances|September 9, 2025
Multifaceted cfDNA profiling in mantle cell lymphomaBrian J Sworder, Alex F Herrera
Blood|March 30, 2019
CAR T cells mimicking an aggressive lymphomaJoo Y Song, Alex F Herrera
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2014
Ibrutinib for the treatment of mantle cell lymphomaAlex F Herrera, Eric D Jacobsen
Haematologica|April 6, 2023
Can we cure relapsed/refractory Hodgkin lymphoma without a stem cell transplant?Matthew G Mei, Alex F Herrera
Current Hematologic Malignancy Reports|August 24, 2018
Updates on Circulating Tumor DNA Assessment in LymphomaJustin M Darrah, Alex F Herrera
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|May 29, 2018
Investigational Antibody-Drug Conjugates for Treatment of B-lineage MalignanciesAlex F Herrera, Arturo Molina
Therapeutic Advances in Hematology|September 14, 2018
Update on the role of brentuximab vedotin in classical Hodgkin lymphomaSarah Tomassetti, Alex F Herrera
Blood|May 25, 2023
The next frontier: enter PD-1 and exit PET scans?Matthew Mei, Alex F Herrera
Hematology. American Society of Hematology. Education Program|December 9, 2022
Incorporating novel agents into frontline treatment of Hodgkin lymphomaSwetha Kambhampati Thiruvengadam, Alex F Herrera
Hematology/Oncology Clinics of North America|February 10, 2026
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin LymphomaAlex F Herrera, Alison J Moskowitz
Blood Advances|September 9, 2025
Multifaceted cfDNA profiling in mantle cell lymphomaBrian J Sworder, Alex F Herrera
Blood|March 30, 2019
CAR T cells mimicking an aggressive lymphomaJoo Y Song, Alex F Herrera
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2014
Ibrutinib for the treatment of mantle cell lymphomaAlex F Herrera, Eric D Jacobsen
Haematologica|April 6, 2023
Can we cure relapsed/refractory Hodgkin lymphoma without a stem cell transplant?Matthew G Mei, Alex F Herrera
Current Hematologic Malignancy Reports|August 24, 2018
Updates on Circulating Tumor DNA Assessment in LymphomaJustin M Darrah, Alex F Herrera
Pageof 18